Home ETF List About

Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for TECH

Stock NameBio-Techne Corp
TickerTECH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09073M1045
LEI54930073RLKQ51TILZ35

Show aggregate TECH holdings

News associated with TECH

Royal Bank Of Canada Upgrades Bio-Techne (NASDAQ:TECH) to “Moderate Buy”
Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
How The Pieces Add Up: TCAF Headed For $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-29 10:39:29
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Cwm LLC
Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Signaturefd LLC
Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC Has $3.25 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH)
Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Xponance Inc.
Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC Grows Position in Bio-Techne Corp (NASDAQ:TECH)
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale Sells 261 Shares of Bio-Techne Corp (NASDAQ:TECH)
DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC Lowers Stake in Bio-Techne Corp (NASDAQ:TECH)
GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust Co
Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH)
Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC Sells 2,582 Shares of Bio-Techne Corp (NASDAQ:TECH)
Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama Sells 430 Shares of Bio-Techne Corp (NASDAQ:TECH)
Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional Invests $27,000 in Bio-Techne Corp (NASDAQ:TECH)
CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of “Hold” from Brokerages
Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. Sells 6,200 Shares of Bio-Techne Corp (NASDAQ:TECH)
Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Bio-Techne (NASDAQ:TECH) Cut to Hold at Wall Street Zen
Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers Increases Position in Bio-Techne Co. (NASDAQ:TECH)
Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC Buys 4,816 Shares of Bio-Techne Co. (NASDAQ:TECH)
Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.08 Million in Bio-Techne Co. (NASDAQ:TECH)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
How The Parts Add Up: XLV Headed For $158
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:22:41
Cetera Investment Advisers Decreases Position in Bio-Techne Co. (NASDAQ:TECH)
Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE Sells 303,523 Shares of Bio-Techne Co. (NASDAQ:TECH)
Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV Reduces Stake in Bio-Techne Co. (NASDAQ:TECH)
Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06

iShares Core S&P 500 UCITS ETF USD (Dist) TECH holdings

DateNumber of TECH Shares HeldBase Market Value of TECH SharesLocal Market Value of TECH SharesChange in TECH Shares HeldChange in TECH Base ValueCurrent Price per TECH Share HeldPrevious Price per TECH Share Held
2025-09-29 (Monday)55,737USD 2,911,144USD 2,911,144
2025-09-26 (Friday)55,737USD 2,889,963USD 2,889,963
2025-09-25 (Thursday)55,737USD 2,813,604USD 2,813,604
2025-09-24 (Wednesday)55,716USD 2,853,774USD 2,853,774
2025-09-18 (Thursday)55,779TECH holding increased by 21USD 2,955,729TECH holding increased by 83077USD 2,955,72921USD 83,077 USD 52.99 USD 51.52
2025-09-17 (Wednesday)55,758TECH holding increased by 21USD 2,872,652TECH holding decreased by -13410USD 2,872,65221USD -13,410 USD 51.52 USD 51.78
2025-09-16 (Tuesday)55,737USD 2,886,062TECH holding increased by 8918USD 2,886,0620USD 8,918 USD 51.78 USD 51.62
2025-09-15 (Monday)55,737USD 2,877,144USD 2,877,144
2025-09-12 (Friday)55,737USD 2,857,079USD 2,857,079
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECH by Blackrock for IE0031442068

Show aggregate share trades of TECH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY21 52.990* 61.33
2025-09-17BUY21 51.520* 61.38
2025-08-19SELL-42 54.870* 61.53 Profit of 2,584 on sale
2025-08-15SELL-21 53.600* 61.62 Profit of 1,294 on sale
2025-08-13SELL-105 54.710* 61.65 Profit of 6,473 on sale
2025-08-12SELL-273 52.830* 61.70 Profit of 16,843 on sale
2025-08-07SELL-315 50.150* 61.76 Profit of 19,454 on sale
2025-08-05BUY21 54.640* 61.86
2025-07-31BUY63 54.730* 61.90
2025-07-28BUY21 58.550* 61.96
2025-07-25SELL-42 58.780* 61.98 Profit of 2,603 on sale
2025-07-18BUY21 52.020* 62.18
2025-07-14SELL-21 52.620* 62.41 Profit of 1,311 on sale
2025-07-08SELL-42 52.680* 62.57 Profit of 2,628 on sale
2025-07-02BUY126 53.180* 62.80
2025-06-24SELL-42 50.000* 63.14 Profit of 2,652 on sale
2025-06-23SELL-21 49.300* 63.23 Profit of 1,328 on sale
2025-06-20SELL-126 49.890* 63.31 Profit of 7,977 on sale
2025-06-12SELL-63 51.530* 63.64 Profit of 4,009 on sale
2025-06-06BUY21 48.690* 63.98
2025-06-02SELL-63 48.610* 64.38 Profit of 4,056 on sale
2025-05-29SELL-21 48.330* 64.60 Profit of 1,357 on sale
2025-05-27BUY21 48.690* 64.82
2025-05-23BUY21 46.780* 65.07
2025-05-21SELL-63 46.660* 65.33 Profit of 4,116 on sale
2025-05-15BUY84 48.240* 65.80
2025-05-14SELL-126 47.860* 65.93 Profit of 8,307 on sale
2025-05-13SELL-252 51.610* 66.04 Profit of 16,641 on sale
2025-05-07SELL-63 48.750* 66.50 Profit of 4,190 on sale
2025-05-02SELL-21 50.490* 66.90 Profit of 1,405 on sale
2025-04-29SELL-63 50.500* 67.30 Profit of 4,240 on sale
2025-04-24BUY21 50.780* 67.71
2025-04-22BUY84 49.080* 68.01
2025-04-16BUY21 49.975* 68.68
2025-04-15BUY21 51.070* 68.83
2025-04-11BUY42 50.720* 69.14
2025-04-09BUY105 54.070* 69.45
2025-04-08BUY315 48.810* 69.63
2025-04-07SELL-147 52.310* 69.79 Profit of 10,259 on sale
2025-04-04SELL-315 51.720* 69.96 Profit of 22,037 on sale
2025-04-02SELL-63 58.380* 70.06 Profit of 4,414 on sale
2025-04-01SELL-21 57.350* 70.18 Profit of 1,474 on sale
2025-03-31SELL-42 58.630* 70.29 Profit of 2,952 on sale
2025-03-28BUY42 58.730* 70.40
2025-03-25BUY63 59.980* 70.72
2025-03-24BUY84 61.070* 70.81
2025-03-21SELL-42 60.610* 70.91 Profit of 2,978 on sale
2025-03-20BUY42 60.340* 71.02
2025-03-19BUY84 60.890* 71.12
2025-03-17SELL-63 62.580* 71.30 Profit of 4,492 on sale
2025-03-14SELL-42 62.160* 71.39 Profit of 2,999 on sale
2025-03-13SELL-126 59.880* 71.52 Profit of 9,011 on sale
2025-03-11SELL-147 58.470* 71.78 Profit of 10,552 on sale
2025-03-10SELL-84 62.900* 71.88 Profit of 6,038 on sale
2025-03-06SELL-84 63.390* 72.06 Profit of 6,053 on sale
2025-03-05SELL-126 62.200* 72.17 Profit of 9,093 on sale
2025-03-04SELL-168 60.120* 72.31 Profit of 12,148 on sale
2025-02-28SELL-105 61.750* 72.56 Profit of 7,619 on sale
2025-02-26BUY42 64.150* 72.80
2025-02-24BUY42 65.560* 73.00
2025-02-21BUY21 64.920* 73.10
2025-02-20SELL-63 65.490* 73.19 Profit of 4,611 on sale
2025-02-14SELL-21 65.940* 73.59 Profit of 1,545 on sale
2025-02-13SELL-273 66.770* 73.68 Profit of 20,116 on sale
2025-02-12SELL-21 67.440* 73.77 Profit of 1,549 on sale
2025-02-06SELL-84 75.010* 73.90 Profit of 6,208 on sale
2025-02-05BUY21 75.250* 73.88
2025-02-04BUY147 72.550* 73.90
2025-01-29SELL-147 71.830* 73.99 Profit of 10,876 on sale
2025-01-28BUY42 74.600* 73.98
2025-01-24BUY21 77.050* 73.88
2025-01-22BUY42 78.710* 73.75
2025-01-16BUY42 76.100* 73.54
2025-01-15BUY21 75.130* 73.51
2025-01-10BUY42 73.310* 73.43
2025-01-02BUY63 71.480* 73.39
2024-12-31BUY42 72.030* 73.42
2024-12-27BUY21 72.980* 73.46
2024-12-20BUY63 73.170* 73.50
2024-12-19BUY21 71.390* 73.55
2024-12-18SELL-21 71.410* 73.61 Profit of 1,546 on sale
2024-12-17BUY42 75.270* 73.57
2024-12-13BUY21 75.690* 73.43
2024-12-11SELL-1,245 76.810* 73.33 Profit of 91,298 on sale
2024-12-10BUY22 77.120* 73.22
2024-12-06SELL-44 74.510* 73.04 Profit of 3,214 on sale
2024-12-05BUY22 73.890* 73.01
2024-12-04SELL-176 75.890* 72.91 Profit of 12,833 on sale
2024-12-03BUY66 75.050* 72.84
2024-12-02BUY110 76.020* 72.72
2024-11-27BUY22 75.380* 72.39
2024-11-26BUY154 74.870* 72.28
2024-11-21BUY66 71.050* 72.28
2024-11-20BUY44 68.720* 72.47
2024-11-19BUY22 66.370* 72.81
2024-11-18BUY44 66.860* 73.16
2024-11-12BUY88 74.410* 73.08
2024-11-11BUY44 74.690* 72.98
2024-11-08BUY176 75.960* 72.76
2024-11-07BUY154 76.420* 72.48
2024-11-06BUY176 75.830* 72.20
2024-11-05SELL-44 77.620* 71.71 Profit of 3,155 on sale
2024-11-04BUY44 75.900* 71.29
2024-11-01BUY154 75.310* 70.84
2024-10-28BUY110 70.380* 69.34
2024-10-25BUY242 68.680* 69.50
2024-10-23SELL-22 69.340* 70.15 Profit of 1,543 on sale
2024-10-21BUY22 70.360* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19651,35111,081870,85674.8%
2025-09-18364,7260635,89757.4%
2025-09-17271,704109711,34538.2%
2025-09-16359,43201,639,77821.9%
2025-09-15279,70130759,61936.8%
2025-09-12389,4061,558859,94245.3%
2025-09-11291,39729720,35140.5%
2025-09-10623,442211,428,22043.7%
2025-09-09496,5733171,091,06945.5%
2025-09-08324,673215797,10140.7%
2025-09-05300,894351736,45040.9%
2025-09-04298,14550849,32735.1%
2025-09-03396,4460721,67254.9%
2025-09-02157,8040635,17724.8%
2025-08-29267,6043,210620,56843.1%
2025-08-28552,63101,621,66434.1%
2025-08-27319,849448770,75941.5%
2025-08-26501,622768647,13777.5%
2025-08-25403,253775980,20941.1%
2025-08-22345,299759513,18267.3%
2025-08-21321,8404618,18452.1%
2025-08-20340,4275602,03456.5%
2025-08-19355,2340523,53767.9%
2025-08-18257,2510489,73252.5%
2025-08-15172,7352321,97653.6%
2025-08-14267,327265566,98647.1%
2025-08-13301,96036655,81446.0%
2025-08-12336,42393800,31842.0%
2025-08-11335,295637799,43341.9%
2025-08-08425,18121,371853,69549.8%
2025-08-07562,06246,8941,314,23842.8%
2025-08-061,493,78312,2823,400,01843.9%
2025-08-05325,3055,603950,69834.2%
2025-08-04295,3211,870616,19947.9%
2025-08-01382,01610,466684,12755.8%
2025-07-31403,7771,690959,80042.1%
2025-07-30313,8576,379528,86459.3%
2025-07-29438,3262,402761,35057.6%
2025-07-28682,9256,9001,041,30065.6%
2025-07-25615,59726,3711,044,88258.9%
2025-07-241,073,71263,0372,073,18551.8%
2025-07-23529,3193,7241,012,04152.3%
2025-07-22346,5822,688608,36257.0%
2025-07-21871,04541,362,95163.9%
2025-07-18384,0621,700787,47848.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.